Select Page
  1. Home
  2.  » 
  3. Our Locations
  4.  » 
  5. Europe
  6.  » Bolton, UK
BOLTON, UK
Our Bolton facility offers state of the art Clinical Trial Supply solutions including the best of technological, air handling, and filtration systems. Our production cubicles range from total protection suites to cubicles with individual environmental control. Separate storage areas in the modern temperature and humidity controlled warehouse are allocated to each component, with cold storage facilities also available for temperature-sensitive products.

Size: 60,830 ft2

If you plan to visit our location soon, please download the Visitor Welcome Guide for more information.

ADDRESS

Lancaster Way, Wingates Industrial Estate
Westhoughton, Bolton, Lancashire UK, BL5 3XX

PHONE

+44 0 1942 790 000

FAX

+44 0 1942 790 000

FEATURED TECHNOLOGIES:

  • Licensed for controlled drug, Cryogenic storage capabilities (liq N² -186°C), 900 pallets space of refrigerated storage capacity (2-8°C)
Title Address Description
Bolton UK Location
Wingates Industrial Park, Lancaster Way, Westhoughton, Bolton BL5 3XX, UK

ACCREDITATIONS

  • MHRA, FDA, ANVISA, SFDA, UK Home Office Approved

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume, or contact us at careers@catalent.com.

GENDER PAY GAP REPORT

Catalent UK Swindon Zydis Limited (“Catalent Zydis”) continues to be an organisation committed to the growth, development, and engagement of our people, within an inclusive culture.  As a UK based organisation of over over 250 employees, we now report our gender pay data. Please download here.

CATALENT UK RETIREMENT AND DEATH BENEFIT PLAN (“PLAN”) – CHAIR’S STATEMENT RELATING TO THE DEFINED CONTRIBUTION SECTION

The defined contribution section of the Plan (DC Section) is now closed and all members’ benefits in the DC Section have been transferred out of the Plan.

Before the DC Section closed, the chair of trustees was required to publish a statement that covered the Statement of Investment Principles (SIP) in relation to the default arrangement and the charges and transaction costs borne by members. The most recent and final chair’s statement was prepared in December 2018 and can be accessed here. Please note that this is a historic document which was prepared before the DC Section closed and is provided for information only.

CATALENT UK TAX STRATEGY

The purpose of this statement is to satisfy the UK legislative requirements of Schedule 19 Finance Act 2016 in relation to the publication of tax strategy insofar as it affects the UK companies in the Catalent group for the year ended 30 June 2019. Please download here.